A.P. Pharma, Inc. (NASDAQ: APPA), a specialty pharmaceutical company, is committed to developing ethical (prescription) pharmaceuticals through the utilization of its proprietary polymer-based drug delivery systems. The Company’s main focus is on developing and commercializing its bioerodible injectable and implantable systems under the trade name Biochronomer™. For further information, visit the Company’s web site at www.appharma.com.
- 17 years ago
QualityStocks
A.P. Pharma, Inc. (NASDAQ: APPA)
Related Post
-
QualityStocksNewsBreaks – BluSky AI Inc. (BSAI) Focused on Scalability in the Era of Artificial Intelligence
BluSky AI (OTC: BSAI) was featured in a recent article that discussed its strategic moves in…
-
QualityStocksNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Advancing Louisiana SMC to Play Pivotal Role in Critical Mineral Supply Chain
Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising.…
-
QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Releases New Datavault Insights Highlighting Execution, Growth and Global Momentum
Datavault AI (NASDAQ: DVLT) released a new Datavault Insights piece detailing the company’s ability to…